Table 3.
Relationship between TG/HDL-c ratio and in-hospital mortality in different models.
| Exposure | OR (95% CI), P value | ||
|---|---|---|---|
| Crude model | Model I | Model II | |
| TG/HDL-c ratio | 2.04 (1.40, 2.97), <0.001 | 2.03 (1.39, 2.95), 0.0002 | 2.08 (1.32, 3.27), 0.002 |
| TG/HDL-c ratio | |||
| Q1 | Ref | Ref | Ref |
| Q2 | 1.15 (0.29, 4.58), 0.847 | 1.17 (0.29, 4.68), 0.824 | 2.56 (0.55, 11.96), 0.231 |
| Q3 | 3.77 (1.27, 11.12), 0.017 | 3.90 (1.31, 11.66), 0.015 | 4.57 (1.28, 16.37), 0.020 |
| Q4 | 4.18 (1.43, 12.25), 0.009 | 3.95 (1.34, 11.61), 0.013 | 5.29 (1.50, 18.70), 0.010 |
| P for trend | <0.0001 | <0.0001 | <0.0001 |
Abbreviations: CI: confidence interval; OR: odds ratio; TG/HDL-c: triglyceride/high-density lipoprotein cholesterol. Crude model adjusted for none. Model I adjusted for gender, BMI, and age. Model II adjusted for gender, age, BMI, hypertension, smoking, atherosclerosis, WBC, PLT, Hb, ALT, AST, Cr, UA, and TnT.